tradingkey.logo
tradingkey.logo
검색

Catalyst Pharmaceuticals Inc

CPRX
관심 목록에 추가
31.490USD
0.0000.00%
종가 07-14 16:00(ET)
3.85B시가총액
17.43P/E TTM

Catalyst Pharmaceuticals Inc 정보 회사

Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing medicines for patients living with rare and difficult-to-treat diseases. The Company markets three drug products: FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone). FIRDAPSE is a treatment for people six years of age or older living with Lambert-Eaton myasthenic syndrome (LEMS). The Company, through its sub-licensee, also offers FIRDAPSE in Canada and Japan. FYCOMPA is a prescription medicine used alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures in people with epilepsy aged four and older and with other medicines to treat primary generalized tonic-clonic seizures in people with epilepsy aged 12 and older. AGAMREE is a corticosteroid with a structure that retains the potent anti-inflammatory effects of traditional corticosteroids used in Duchenne muscular dystrophy.

Catalyst Pharmaceuticals Inc 프로필

종목 코드 CPRX
회사 이름Catalyst Pharmaceuticals Inc
상장일Nov 08, 2006
CEODaly (Richard J)
직원 수181
유형Ordinary Share
회계 연도 종료Nov 08
주소355 Alhambra Circle
도시CORAL GABLES
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호33134
전화13055292522
웹사이트https://catalystpharma.com/
종목 코드 CPRX
상장일Nov 08, 2006
CEODaly (Richard J)

Catalyst Pharmaceuticals Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Steven R. Miller, Ph.D.
Dr. Steven R. Miller, Ph.D.
Executive Vice President, Chief Operating Officer, and Chief Scientific Officer
Executive Vice President, Chief Operating Officer, and Chief Scientific Officer
1.09M
--
Mr. Donald A. Denkhaus
Mr. Donald A. Denkhaus
Independent Director
Independent Director
498.77K
--
Dr. David S. Tierney, M.D.
Dr. David S. Tierney, M.D.
Independent Director
Independent Director
383.31K
--
Mr. Richard J. (Rich) Daly
Mr. Richard J. (Rich) Daly
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
271.27K
--
Mr. Brian D. Elsbernd, J.D.
Mr. Brian D. Elsbernd, J.D.
Chief Compliance Officer, Chief Legal Officer
Chief Compliance Officer, Chief Legal Officer
242.50K
--
Dr. Gary Ingenito, M.D., Ph.D.
Dr. Gary Ingenito, M.D., Ph.D.
Chief Medical Officer and Regulatory Officer
Chief Medical Officer and Regulatory Officer
68.87K
--
Dr. Preethi Sundaram, Ph.D.
Dr. Preethi Sundaram, Ph.D.
Chief Strategy Officer
Chief Strategy Officer
54.80K
--
Mr. Jeffrey Del Carmen
Mr. Jeffrey Del Carmen
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
14.34K
--
Ms. Tamar Thompson
Ms. Tamar Thompson
Independent Director
Independent Director
3.77K
--
Ms. Molly Harper
Ms. Molly Harper
Lead Independent Director
Lead Independent Director
3.69K
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Steven R. Miller, Ph.D.
Dr. Steven R. Miller, Ph.D.
Executive Vice President, Chief Operating Officer, and Chief Scientific Officer
Executive Vice President, Chief Operating Officer, and Chief Scientific Officer
1.09M
--
Mr. Donald A. Denkhaus
Mr. Donald A. Denkhaus
Independent Director
Independent Director
498.77K
--
Dr. David S. Tierney, M.D.
Dr. David S. Tierney, M.D.
Independent Director
Independent Director
383.31K
--
Mr. Richard J. (Rich) Daly
Mr. Richard J. (Rich) Daly
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
271.27K
--
Mr. Brian D. Elsbernd, J.D.
Mr. Brian D. Elsbernd, J.D.
Chief Compliance Officer, Chief Legal Officer
Chief Compliance Officer, Chief Legal Officer
242.50K
--
Dr. Gary Ingenito, M.D., Ph.D.
Dr. Gary Ingenito, M.D., Ph.D.
Chief Medical Officer and Regulatory Officer
Chief Medical Officer and Regulatory Officer
68.87K
--

자주 묻는 질문

Catalyst Pharmaceuticals Inc의 상위 5대 주주는 누구인가요?

Catalyst Pharmaceuticals Inc의 상위 5대 주주는 다음과 같습니다: Dr. Steven R. Miller, Ph.D.

Catalyst Pharmaceuticals Inc(CPRX)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Catalyst Pharmaceuticals Inc의 주식을 보유한 기관은 총 744곳이며, 이들이 보유한 주식의 총 가치는 약 110.54M로 전체 발행 주식의 90.33%를 차지합니다. 이는 2025Q4 대비 -4945087.00 증가한 수치입니다.
tradingkey.logo
위험 경고: 저희 웹사이트와 모바일 앱은 특정 투자 상품에 대한 일반적인 정보만을 제공합니다. Finsights는 재정적 조언이나 투자 상품에 대한 추천을 제공하지 않으며, 이러한 정보 제공이 Finsights가 금융 조언이나 추천을 제공하는 것으로 해석되어서는 안 됩니다.
투자 상품은 투자 원금 손실을 포함한 상당한 투자 위험에 노출되어 있으며, 모든 사람에게 적합하지 않을 수 있습니다. 투자 상품의 과거 성과는 미래 성과를 보장하지 않습니다.
Finsights는 제3자 광고주나 제휴사가 저희 웹사이트나 모바일 앱 또는 그 일부에 광고를 게재하거나 전달할 수 있도록 허용할 수 있으며, 사용자가 광고와 상호작용하는 방식에 따라 이들로부터 보상을 받을 수 있습니다.
© 저작권: FINSIGHTS MEDIA PTE. LTD. 모든 권리 보유